Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor Tkachev

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Blood Advances|November 2, 2022
Chronic GvHD NIH Consensus Project Biology Task Force: evolving path to personalized treatment of chronic GvHDNataliya P Buxbaum, Gerard Socié, Geoffrey R Hill, et al.
Blood|October 21, 2016
Systems analysis uncovers inflammatory Th/Tc17-driven modules during acute GVHD in monkey and human T cellsScott N Furlan, Benjamin Watkins, Victor Tkachev, et al.
Cells|May 13, 2023
Distinct Traits of Structural and Regulatory Evolutional Conservation of Human Genes with Specific Focus on Major Cancer Molecular PathwaysGalina Zakharova, Alexander Modestov, Polina Pugacheva, et al.
Cell Cycle (Georgetown, Tex.)|August 22, 2017
Data aggregation at the level of molecular pathways improves stability of experimental transcriptomic and proteomic dataNicolas Borisov, Maria Suntsova, Maxim Sorokin, et al.
Biorxiv : the Preprint Server for Biology|July 14, 2025
Precision Editing of Cyclophilin A Generates Cyclosporine and Voclosporin Resistant Cellular TherapiesHolly Wobma, Francesca Alvarez Calderon, Jiayi Dong, et al.
Science Translational Medicine|September 22, 2017
Combined OX40L and mTOR blockade controls effector T cell activation while preserving T<sub>reg</sub> reconstitution after transplantVictor Tkachev, Scott N Furlan, Benjamin Watkins, et al.
Blood|April 1, 2024
B-cell-directed CAR T-cell therapy activates CD8+ cytotoxic CARneg bystander T cells in patients and nonhuman primatesJames Kaminski, Ryan A Fleming, Francesca Alvarez-Calderon, et al.
Science Translational Medicine|November 27, 2015
Transcriptome analysis of GVHD reveals aurora kinase A as a targetable pathway for disease preventionScott N Furlan, Benjamin Watkins, Victor Tkachev, et al.
The Journal of Clinical Investigation|August 14, 2018
CD28 blockade controls T cell activation to prevent graft-versus-host disease in primatesBenjamin K Watkins, Victor Tkachev, Scott N Furlan, et al.
Cancer Discovery|March 23, 2018
Chimeric Antigen Receptor T Cell-Mediated Neurotoxicity in Nonhuman PrimatesAgne Taraseviciute, Victor Tkachev, Rafael Ponce, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Blood Advances|November 2, 2022
Chronic GvHD NIH Consensus Project Biology Task Force: evolving path to personalized treatment of chronic GvHDNataliya P Buxbaum, Gerard Socié, Geoffrey R Hill, et al.
Blood|October 21, 2016
Systems analysis uncovers inflammatory Th/Tc17-driven modules during acute GVHD in monkey and human T cellsScott N Furlan, Benjamin Watkins, Victor Tkachev, et al.
Cells|May 13, 2023
Distinct Traits of Structural and Regulatory Evolutional Conservation of Human Genes with Specific Focus on Major Cancer Molecular PathwaysGalina Zakharova, Alexander Modestov, Polina Pugacheva, et al.
Cell Cycle (Georgetown, Tex.)|August 22, 2017
Data aggregation at the level of molecular pathways improves stability of experimental transcriptomic and proteomic dataNicolas Borisov, Maria Suntsova, Maxim Sorokin, et al.
Biorxiv : the Preprint Server for Biology|July 14, 2025
Precision Editing of Cyclophilin A Generates Cyclosporine and Voclosporin Resistant Cellular TherapiesHolly Wobma, Francesca Alvarez Calderon, Jiayi Dong, et al.
Science Translational Medicine|September 22, 2017
Combined OX40L and mTOR blockade controls effector T cell activation while preserving T<sub>reg</sub> reconstitution after transplantVictor Tkachev, Scott N Furlan, Benjamin Watkins, et al.
Blood|April 1, 2024
B-cell-directed CAR T-cell therapy activates CD8+ cytotoxic CARneg bystander T cells in patients and nonhuman primatesJames Kaminski, Ryan A Fleming, Francesca Alvarez-Calderon, et al.
Science Translational Medicine|November 27, 2015
Transcriptome analysis of GVHD reveals aurora kinase A as a targetable pathway for disease preventionScott N Furlan, Benjamin Watkins, Victor Tkachev, et al.
The Journal of Clinical Investigation|August 14, 2018
CD28 blockade controls T cell activation to prevent graft-versus-host disease in primatesBenjamin K Watkins, Victor Tkachev, Scott N Furlan, et al.
Cancer Discovery|March 23, 2018
Chimeric Antigen Receptor T Cell-Mediated Neurotoxicity in Nonhuman PrimatesAgne Taraseviciute, Victor Tkachev, Rafael Ponce, et al.
Pageof 7